Literature DB >> 9820439

Blood pressure control in dialysis patients: importance of the lag phenomenon.

B Charra1, J Bergström, B H Scribner.   

Abstract

Failure by the world dialysis community to understand and use the dry-weight method of blood pressure (BP) control has resulted in an increasing incidence of treatment-resistant hypertension, which remains the principal cause of cardiovascular morbidity and mortality. This failure may in part be because the relationship between the extracellular volume (ECV) and BP is not simple and linear, but complex, because of a lag of several weeks between the normalization of the time-averaged ECV and the decrease in BP. Another cause for this failure may be the unwillingness to taper and stop all antihypertensive medications during the transition from hypertension to normotension. In this report, we describe in detail the lag phenomenon, document its presence during treatment in other populations, and describe how this knowledge is used in the application of the dry-weight method of drug-free BP control in the dialysis population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820439     DOI: 10.1016/s0272-6386(98)70147-7

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  20 in total

Review 1.  Effect of excessive salt intake: role of plasma sodium.

Authors:  Stefan Reuter; Eckhart Büssemaker; Martin Hausberg; Hermann Pavenstädt; Uta Hillebrand
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

Review 2.  The growing problem of intradialytic hypertension.

Authors:  Francesco Locatelli; Andrea Cavalli; Benedetta Tucci
Journal:  Nat Rev Nephrol       Date:  2009-11-24       Impact factor: 28.314

Review 3.  The controversies of diagnosing and treating hypertension among hemodialysis patients.

Authors:  Rajiv Agarwal
Journal:  Semin Dial       Date:  2012-06-11       Impact factor: 3.455

4.  Individualized reduction in dialysate sodium in conventional in-center hemodialysis.

Authors:  Rohini Arramreddy; Sumi J Sun; Jair Munoz Mendoza; Glenn M Chertow; Brigitte Schiller
Journal:  Hemodial Int       Date:  2012-05-04       Impact factor: 1.812

5.  Effect of lowering dialysate sodium concentration on interdialytic weight gain and blood pressure in patients undergoing thrice-weekly in-center nocturnal hemodialysis: a quality improvement study.

Authors:  Jair Munoz Mendoza; Liz Y Bayes; Sumi Sun; Sheila Doss; Brigitte Schiller
Journal:  Am J Kidney Dis       Date:  2011-08-27       Impact factor: 8.860

6.  Dialysis unphysiology and sodium balance.

Authors:  Gheun-Ho Kim
Journal:  Electrolyte Blood Press       Date:  2009-12-31

7.  Blood volume monitoring to adjust dry weight in hypertensive pediatric hemodialysis patients.

Authors:  Cengiz Candan; Lale Sever; Mahmut Civilibal; Salim Caliskan; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2008-09-10       Impact factor: 3.714

8.  Olmesartan clinical trial in Okinawan patients under OKIDS (OCTOPUS) study: design and methods.

Authors:  Kunitoshi Iseki; Kiyoyuki Tokuyama; Yoshiki Shiohira; Akira Higa; Hiroshi Hirano; Shigeki Toma; Kentaro Kohagura; Shinichiro Ueda
Journal:  Clin Exp Nephrol       Date:  2008-12-20       Impact factor: 2.801

9.  Use of lung ultrasonography to determine the accuracy of clinically estimated dry weight in chronic hemodialysis patients.

Authors:  Chuan Jiang; Satyam Patel; Andrew Moses; Maria V DeVita; Michael F Michelis
Journal:  Int Urol Nephrol       Date:  2017-10-03       Impact factor: 2.370

10.  Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial.

Authors:  Rajiv Agarwal; Pooneh Alborzi; Sangeetha Satyan; Robert P Light
Journal:  Hypertension       Date:  2009-01-19       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.